Physician profile
Mohit Batra
NPI 1386211563
$2,411.18
in general payments reported to CMS, 2019-2025
16 companies · $713 in 2025
The $713 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $724 · 2023: $268 · 2024: $572 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,552.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $416.03 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $405.32 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $401.21 | 2024-2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $187.22 | 2022-2024 | |
| Heru, INC. | $153.51 | 2022 | |
| Alcon Vision LLC | $125.00 | 2025 | Tryptyr |
| Johnson & Johnson Vision Care, INC. | $125.00 | 2025 | Acuvue |
| Rxsight INC | $124.43 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Kala Pharmaceuticals, INC. | $118.39 | 2021 | |
| Eyevance Pharmaceuticals LLC | $117.15 | 2022 | |
| Allergan, INC. | $106.00 | 2022 | |
| Biotissue Holdings INC. | $62.35 | 2022 | |
| Dompe US, INC. | $22.33 | 2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $16.67 | 2022 | |
| Coopervision INC. | $16.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $14.57 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.